Clinical Trials Browser

Phase 1 × Terminated × Endocrine × Clear all

NCT04895748 2026-03-03

DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell, von Hippel-Lindau Disease, Paraganglioma, Pheochromocytoma

NCT03746431 2026-01-07

A Phase 1 Study of [225Ac]-FPI-1434 Injection

Phase 1 Terminated

78 enrolled

BreastDermatologicEndocrineGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Adrenocortical Carcinoma, Triple Negative Breast Neoplasms

NCT05364944 2025-11-17

OXTEND-01

Phase 1 Terminated

19 enrolled

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Acromegaly

NCT03469011 2025-06-27

A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.

Phase 1 Terminated

14 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT03466216 2025-06-10

Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET

Phase 1 Terminated

33 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT04893759 2025-04-17

A Study of Pelcitoclax (APG-1252) in Patients With Neuroendocrine Tumors

Phase 1 Terminated

2 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT02464007 2025-02-25

Study of rSIFN-co for Patients With Advanced Solid Tumors

Phase 1 Terminated

7 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT05999292 2024-12-09

Phase 1 Study of 68Ga-R8760

Phase 1 Terminated

11 enrolled

Endocrine

Adrenocortical Carcinoma

NCT02943733 2022-09-23

Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs

Phase 1 Terminated

18 enrolled

EndocrineNET

Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT04258592 2022-08-12

18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors

Phase 1 Terminated

6 enrolled

EndocrineNET

Neural crest tumor, Neuroendocrine Tumors

NCT02012231 2020-10-19

Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.

Phase 1 Terminated

5 enrolled

DermatologicEndocrineGastrointestinalHead & NeckMyeloidOther hematologic neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Leukemia, Hairy Cell, Melanoma, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis, Cholangiocarcinoma, Thyroid Carcinoma, Anaplastic

NCT01165658 2020-01-02

Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies

Phase 1 Terminated

30 enrolled

EndocrineThoracic

Carcinoid Tumor, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thymus Neoplasms, Small Cell Lung Carcinoma

NCT03014297 2019-08-08

Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression

Phase 1 Terminated

17 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT02629549 2019-08-06

Intraoperative Imaging of Pituitary Adenomas by OTL

Phase 1 Terminated

33 enrolled

Endocrine

Neoplasms, Pituitary Neoplasms

NCT01115803 2019-02-05

A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors

Phase 1 Terminated

29 enrolled 19 charts

EndocrineGenitourinaryNETThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasm Metastasis, Neuroendocrine Tumors

NCT03145909 2018-11-29

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Phase 1 Terminated

19 enrolled

BreastEndocrineGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms, Adrenocortical Carcinoma

NCT01508104 2017-08-23

Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors

Phase 1 Terminated

19 enrolled

CNSEndocrineNET

Brain Neoplasms, Glioblastoma, Neoplasms, Neuroendocrine Tumors

NCT02359500 2017-05-03

68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs)

Phase 1 Terminated

71 enrolled

EndocrineNET

Carcinoid Tumor, Disease, Neuroendocrine Tumors

NCT01832974 2015-04-27

Possible New Therapy for Advanced Cancer

Phase 1 Terminated

9 enrolled

Endocrine

Adrenal Gland Neoplasms, Neoplasm Metastasis, Adrenocortical Carcinoma

NCT01088763 2014-11-05

Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

Phase 1 Terminated

129 enrolled

CNSEndocrineLymphoidOther hematologic neoplasmSarcoma

Familial ependymoma, Adenoma, Basophil, Adenoma, Chromophobe, Adenoma, Acidophil, Astrocytoma, Burkitt Lymphoma, Medulloblastoma, Oligodendroglioma, Pituitary Neoplasms, Recurrence, Spinal Cord Neoplasms, Prolactinoma, Choroid Plexus Neoplasms, Lymphoma, Large-Cell, Anaplastic, Rhabdoid Tumor, Optic Nerve Glioma, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT00002947 2014-07-02

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Phase 1 Terminated

35 enrolled

CNSDermatologicEndocrineGenitourinaryHead & NeckThoracic

Uveal Melanoma, Carcinoma, Renal Cell, Vipoma, Glucagonoma, Head and Neck Neoplasms, Insulinoma, Adenoma, Islet Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Pheochromocytoma, Somatostatinoma, Carcinoma, Merkel Cell, Gastrinoma, Central Nervous System Neoplasms, Carcinoma, Islet Cell, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma